FDA Inspection 1334932 — Detroit Medical Center University Laboratories
The FDA completed an inspection of Detroit Medical Center University Laboratories on Aug 6, 2026 in Detroit, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 6, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Detroit, MI (United States)